VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Amgen Inc. vs Cboe Global Markets, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Amgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Cboe Global Markets, Inc.
CBOE · Cboe BZX
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Cboe Global Markets, Inc.'s moat claims, evidence, and risks.
View CBOE analysisComparison highlights
- Moat score gap: Cboe Global Markets, Inc. leads (76 / 100 vs 70 / 100 for Amgen Inc.).
- Segment focus: Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines); Cboe Global Markets, Inc. has 5 segments (60.8% in Options).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Amgen Inc. has 5 moat types across 3 domains; Cboe Global Markets, Inc. has 8 across 4.
Primary market context
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
Cboe Global Markets, Inc.
Options
U.S. listed options exchanges (multi-listed + proprietary index options)
United States
Broker-dealers, market makers, institutional investors, retail order-flow intermediaries
Exchange operator (SRO) + derivatives listing venue + market data provider
60.8%
Side-by-side metrics
Moat coverage
Shared moat types
Amgen Inc. strengths
Cboe Global Markets, Inc. strengths
Segment mix
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
Cboe Global Markets, Inc. segments
Full profile >Options
Oligopoly
North American Equities
Competitive
Europe and Asia Pacific
Oligopoly
Futures
Quasi-Monopoly
Global FX
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.